Fabrizio Santori
About Fabrizio Santori
Fabrizio Santori is the Oncology New Indications Lead at Bristol-Myers Squibb, with extensive experience in product management across various pharmaceutical companies.
Company
Fabrizio Santori is currently employed at Bristol-Myers Squibb. He has been with the company for several years, assuming various roles and responsibilities within the oncology and pharmaceuticals divisions.
Title
Fabrizio Santori serves as the Oncology New Indications Lead at Bristol-Myers Squibb. In addition to this role, he also holds the position of Franchise Lead for Melanoma.
Professional Experience
Fabrizio Santori has an extensive background in the pharmaceutical industry. Before his current roles, he served as Senior Product Manager for Onco Hematology at Bristol-Myers Squibb from 2013 to 2014. From 2009 to 2013, he was the Senior Product Manager for Cardiovascular and Metabolic products at Bristol-Myers Squibb. Prior to this, he worked at Takeda Italia as a Senior Product Manager from 2007 to 2009, and at Solvay Pharmaceuticals as a Product Manager from 2003 to 2007.
Education and Expertise
Fabrizio Santori achieved a Master's degree from LUISS Guido Carli University, where he studied from 2008 to 2009. He also completed a two-year program from 2000 to 2002 and earned his undergraduate degree from Università degli Studi Camerino, where he studied from 1995 to 2000.
Background
With a robust educational background and over a decade of experience in the pharmaceutical industry, Fabrizio Santori has built a career focusing on oncology, cardiovascular, and metabolic products. His roles at major pharmaceutical companies such as Bristol-Myers Squibb, Takeda Italia, and Solvay Pharmaceuticals have equipped him with in-depth industry knowledge and strategic management skills.